nodes	percent_of_prediction	percent_of_DWPC	metapath
Alprenolol—HTR1A—bipolar disorder	0.844	1	CbGaD
Alprenolol—Penbutolol—HTR1A—bipolar disorder	0.00127	0.473	CrCbGaD
Alprenolol—Pindolol—HTR1A—bipolar disorder	0.000916	0.341	CrCbGaD
Alprenolol—HTR1A—telencephalic ventricle—bipolar disorder	0.000662	0.321	CbGeAlD
Alprenolol—Propranolol—HTR1A—bipolar disorder	0.0005	0.186	CrCbGaD
Alprenolol—CYP2D6—urine—bipolar disorder	0.000328	0.159	CbGeAlD
Alprenolol—HTR1A—blood plasma—bipolar disorder	0.000315	0.153	CbGeAlD
Alprenolol—CYP2D6—blood plasma—bipolar disorder	0.000171	0.0831	CbGeAlD
Alprenolol—ADRB3—Signaling by GPCR—TAC1—bipolar disorder	0.000116	0.000769	CbGpPWpGaD
Alprenolol—ADRB1—GPCR ligand binding—DRD2—bipolar disorder	0.000115	0.000764	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—RGS4—bipolar disorder	0.000115	0.000763	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—DRD5—bipolar disorder	0.000115	0.00076	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—DRD1—bipolar disorder	0.000114	0.000754	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—HTR2C—bipolar disorder	0.000114	0.000754	CbGpPWpGaD
Alprenolol—ADRB2—GPCR ligand binding—DRD2—bipolar disorder	0.000113	0.000747	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—RGS4—bipolar disorder	0.000112	0.000746	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—ADCY2—bipolar disorder	0.000111	0.000735	CbGpPWpGaD
Alprenolol—HTR1A—GPCR ligand binding—DRD2—bipolar disorder	0.00011	0.000731	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—DRD3—bipolar disorder	0.00011	0.000731	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—DRD2—bipolar disorder	0.00011	0.000728	CbGpPWpGaD
Alprenolol—ADRB1—nervous system—bipolar disorder	0.000109	0.0531	CbGeAlD
Alprenolol—ADRB3—GPCR ligand binding—POMC—bipolar disorder	0.000109	0.00072	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—DRD4—bipolar disorder	0.000107	0.000709	CbGpPWpGaD
Alprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—bipolar disorder	0.000106	0.000703	CbGpPWpGaD
Alprenolol—HTR1A—SIDS Susceptibility Pathways—IL1B—bipolar disorder	0.000105	0.000695	CbGpPWpGaD
Alprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—bipolar disorder	0.000104	0.000687	CbGpPWpGaD
Alprenolol—CYP2D6—Biological oxidations—COMT—bipolar disorder	0.000103	0.000687	CbGpPWpGaD
Alprenolol—CYP2D6—Biological oxidations—MAOA—bipolar disorder	0.000103	0.000682	CbGpPWpGaD
Alprenolol—CYP2D6—Metapathway biotransformation—COMT—bipolar disorder	0.000102	0.000677	CbGpPWpGaD
Alprenolol—HTR1A—G alpha (i) signalling events—POMC—bipolar disorder	0.000102	0.000675	CbGpPWpGaD
Alprenolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—bipolar disorder	0.000101	0.000672	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—ADCY2—bipolar disorder	0.000101	0.000668	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—TRPC3—bipolar disorder	0.0001	0.000663	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—DRD2—bipolar disorder	9.96e-05	0.000661	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—TRPC3—bipolar disorder	9.78e-05	0.000649	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—TRPC3—bipolar disorder	9.56e-05	0.000635	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—ADM—bipolar disorder	9.54e-05	0.000633	CbGpPWpGaD
Alprenolol—HTR1A—nervous system—bipolar disorder	9.38e-05	0.0455	CbGeAlD
Alprenolol—ADRB2—GPCR downstream signaling—ADM—bipolar disorder	9.33e-05	0.000619	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—TSHB—bipolar disorder	9.3e-05	0.000617	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—PDE4B—bipolar disorder	9.3e-05	0.000617	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—TACR1—bipolar disorder	9.3e-05	0.000617	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—ADM—bipolar disorder	9.12e-05	0.000605	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—PDE4B—bipolar disorder	9.09e-05	0.000603	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—TSHB—bipolar disorder	9.09e-05	0.000603	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—TACR1—bipolar disorder	9.09e-05	0.000603	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—TRPC3—bipolar disorder	9.08e-05	0.000602	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—TRPC3—bipolar disorder	9.04e-05	0.0006	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—TSHB—bipolar disorder	8.89e-05	0.00059	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—PDE4B—bipolar disorder	8.89e-05	0.00059	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—TACR1—bipolar disorder	8.89e-05	0.00059	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—TRPC3—bipolar disorder	8.88e-05	0.000589	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—IMPA2—bipolar disorder	8.86e-05	0.000588	CbGpPWpGaD
Alprenolol—HTR1A—cerebellum—bipolar disorder	8.83e-05	0.0428	CbGeAlD
Alprenolol—HTR1A—Signaling by GPCR—TRPC3—bipolar disorder	8.68e-05	0.000576	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—ADM—bipolar disorder	8.66e-05	0.000575	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—ADM—bipolar disorder	8.62e-05	0.000572	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—ADM—bipolar disorder	8.47e-05	0.000562	CbGpPWpGaD
Alprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—POMC—bipolar disorder	8.46e-05	0.000561	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—PDE4B—bipolar disorder	8.44e-05	0.00056	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—TSHB—bipolar disorder	8.44e-05	0.00056	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—TACR1—bipolar disorder	8.44e-05	0.00056	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—AKR1C4—bipolar disorder	8.41e-05	0.000558	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—TSHB—bipolar disorder	8.4e-05	0.000557	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—PDE4B—bipolar disorder	8.4e-05	0.000557	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—TACR1—bipolar disorder	8.4e-05	0.000557	CbGpPWpGaD
Alprenolol—ADRB1—brain—bipolar disorder	8.36e-05	0.0406	CbGeAlD
Alprenolol—HTR1A—Signaling by GPCR—ADM—bipolar disorder	8.29e-05	0.00055	CbGpPWpGaD
Alprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—POMC—bipolar disorder	8.28e-05	0.000549	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—TSHB—bipolar disorder	8.26e-05	0.000548	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—TACR1—bipolar disorder	8.26e-05	0.000548	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—PDE4B—bipolar disorder	8.26e-05	0.000548	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—AKR1C4—bipolar disorder	8.23e-05	0.000546	CbGpPWpGaD
Alprenolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—POMC—bipolar disorder	8.09e-05	0.000537	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—TSHB—bipolar disorder	8.07e-05	0.000536	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—PDE4B—bipolar disorder	8.07e-05	0.000536	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—TACR1—bipolar disorder	8.07e-05	0.000536	CbGpPWpGaD
Alprenolol—ADRB1—GPCR ligand binding—HTR2A—bipolar disorder	8.07e-05	0.000535	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—AKR1C4—bipolar disorder	8.04e-05	0.000534	CbGpPWpGaD
Alprenolol—ADRB2—GPCR ligand binding—HTR2A—bipolar disorder	7.89e-05	0.000524	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—DGKH—bipolar disorder	7.74e-05	0.000513	CbGpPWpGaD
Alprenolol—HTR1A—GPCR ligand binding—HTR2A—bipolar disorder	7.72e-05	0.000512	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—HTR1A—bipolar disorder	7.69e-05	0.00051	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—HTR2A—bipolar disorder	7.68e-05	0.00051	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—TAC1—bipolar disorder	7.58e-05	0.000503	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—DGKH—bipolar disorder	7.57e-05	0.000502	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—HTR1A—bipolar disorder	7.53e-05	0.000499	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—HTR2C—bipolar disorder	7.43e-05	0.000493	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—DRD1—bipolar disorder	7.43e-05	0.000493	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—TAC1—bipolar disorder	7.41e-05	0.000492	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—DGKH—bipolar disorder	7.4e-05	0.000491	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—DRD1—bipolar disorder	7.27e-05	0.000482	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—HTR2C—bipolar disorder	7.27e-05	0.000482	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—TAC1—bipolar disorder	7.25e-05	0.000481	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—DRD3—bipolar disorder	7.2e-05	0.000477	CbGpPWpGaD
Alprenolol—HTR1A—brain—bipolar disorder	7.17e-05	0.0348	CbGeAlD
Alprenolol—HTR1A—GPCR downstream signaling—HTR2C—bipolar disorder	7.11e-05	0.000472	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—DRD1—bipolar disorder	7.11e-05	0.000472	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—DRD5—bipolar disorder	7.08e-05	0.00047	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—DRD3—bipolar disorder	7.04e-05	0.000467	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—HTR1A—bipolar disorder	6.99e-05	0.000464	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—DRD4—bipolar disorder	6.99e-05	0.000464	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—HTR2A—bipolar disorder	6.97e-05	0.000463	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—HTR1A—bipolar disorder	6.95e-05	0.000461	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—RGS4—bipolar disorder	6.94e-05	0.00046	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—DRD5—bipolar disorder	6.92e-05	0.000459	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—DRD3—bipolar disorder	6.88e-05	0.000457	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—TAC1—bipolar disorder	6.88e-05	0.000457	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—TAC1—bipolar disorder	6.85e-05	0.000454	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—HTR1A—bipolar disorder	6.83e-05	0.000453	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—DRD4—bipolar disorder	6.83e-05	0.000453	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—RGS4—bipolar disorder	6.79e-05	0.00045	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—DRD5—bipolar disorder	6.77e-05	0.000449	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—HTR2C—bipolar disorder	6.75e-05	0.000448	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—DRD1—bipolar disorder	6.75e-05	0.000448	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—TAC1—bipolar disorder	6.73e-05	0.000447	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—HTR2C—bipolar disorder	6.72e-05	0.000446	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—DRD1—bipolar disorder	6.72e-05	0.000446	CbGpPWpGaD
Alprenolol—CYP2D6—Biological oxidations—POMC—bipolar disorder	6.69e-05	0.000444	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—DRD4—bipolar disorder	6.68e-05	0.000443	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—RGS4—bipolar disorder	6.64e-05	0.00044	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—DRD1—bipolar disorder	6.6e-05	0.000438	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—HTR2C—bipolar disorder	6.6e-05	0.000438	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—TAC1—bipolar disorder	6.58e-05	0.000437	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—ADCY2—bipolar disorder	6.58e-05	0.000436	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—DRD3—bipolar disorder	6.54e-05	0.000434	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—NTRK2—bipolar disorder	6.53e-05	0.000433	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—DRD2—bipolar disorder	6.51e-05	0.000432	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—DRD3—bipolar disorder	6.5e-05	0.000432	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—GSK3A—bipolar disorder	6.48e-05	0.00043	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—HTR2C—bipolar disorder	6.45e-05	0.000428	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—DRD1—bipolar disorder	6.45e-05	0.000428	CbGpPWpGaD
Alprenolol—ADRB1—GPCR ligand binding—POMC—bipolar disorder	6.44e-05	0.000427	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—ADCY2—bipolar disorder	6.43e-05	0.000427	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—DRD3—bipolar disorder	6.39e-05	0.000424	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—DRD2—bipolar disorder	6.37e-05	0.000422	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—DRD4—bipolar disorder	6.34e-05	0.000421	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—DRD4—bipolar disorder	6.31e-05	0.000419	CbGpPWpGaD
Alprenolol—ADRB2—GPCR ligand binding—POMC—bipolar disorder	6.3e-05	0.000418	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—ADCY2—bipolar disorder	6.29e-05	0.000417	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—DRD3—bipolar disorder	6.25e-05	0.000415	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—DRD2—bipolar disorder	6.23e-05	0.000413	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—DRD4—bipolar disorder	6.21e-05	0.000412	CbGpPWpGaD
Alprenolol—HTR1A—GPCR ligand binding—POMC—bipolar disorder	6.16e-05	0.000409	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—POMC—bipolar disorder	6.13e-05	0.000407	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—DRD4—bipolar disorder	6.07e-05	0.000403	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—IMPA1—bipolar disorder	5.98e-05	0.000397	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—ADCY2—bipolar disorder	5.97e-05	0.000396	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—ADCY2—bipolar disorder	5.94e-05	0.000394	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—TCF7L2—bipolar disorder	5.92e-05	0.000393	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—DRD2—bipolar disorder	5.91e-05	0.000392	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—DRD2—bipolar disorder	5.88e-05	0.00039	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—ADCY2—bipolar disorder	5.84e-05	0.000388	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—DRD2—bipolar disorder	5.78e-05	0.000384	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—ADCY2—bipolar disorder	5.71e-05	0.000379	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—DRD2—bipolar disorder	5.65e-05	0.000375	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—POMC—bipolar disorder	5.57e-05	0.00037	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—TRPC3—bipolar disorder	5.36e-05	0.000356	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—NTRK1—bipolar disorder	5.33e-05	0.000353	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—TRPC3—bipolar disorder	5.25e-05	0.000348	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—S100B—bipolar disorder	5.18e-05	0.000344	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—TRPC3—bipolar disorder	5.13e-05	0.00034	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—ADM—bipolar disorder	5.12e-05	0.000339	CbGpPWpGaD
Alprenolol—CYP2D6—nervous system—bipolar disorder	5.09e-05	0.0247	CbGeAlD
Alprenolol—CYP2D6—Metabolism—NDUFV2—bipolar disorder	5.09e-05	0.000337	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—ADM—bipolar disorder	5.01e-05	0.000332	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—PDE4B—bipolar disorder	4.99e-05	0.000331	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—TSHB—bipolar disorder	4.99e-05	0.000331	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—TACR1—bipolar disorder	4.99e-05	0.000331	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—AKR1C4—bipolar disorder	4.93e-05	0.000327	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—ADM—bipolar disorder	4.89e-05	0.000325	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—TSHB—bipolar disorder	4.88e-05	0.000324	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—PDE4B—bipolar disorder	4.88e-05	0.000324	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—TACR1—bipolar disorder	4.88e-05	0.000324	CbGpPWpGaD
Alprenolol—CYP2D6—cerebellum—bipolar disorder	4.79e-05	0.0233	CbGeAlD
Alprenolol—HTR1A—Signaling Pathways—TSHB—bipolar disorder	4.77e-05	0.000316	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—PDE4B—bipolar disorder	4.77e-05	0.000316	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—TACR1—bipolar disorder	4.77e-05	0.000316	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—NRG1—bipolar disorder	4.57e-05	0.000303	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—HTR2A—bipolar disorder	4.56e-05	0.000302	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—HTR2A—bipolar disorder	4.46e-05	0.000296	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—NR1D1—bipolar disorder	4.42e-05	0.000294	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—HTR2A—bipolar disorder	4.36e-05	0.000289	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—NCAN—bipolar disorder	4.23e-05	0.000281	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—SLC5A3—bipolar disorder	4.15e-05	0.000275	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—HTR2A—bipolar disorder	4.14e-05	0.000275	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—HTR1A—bipolar disorder	4.13e-05	0.000274	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—HTR2A—bipolar disorder	4.12e-05	0.000273	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—TAC1—bipolar disorder	4.06e-05	0.00027	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—HTR2A—bipolar disorder	4.05e-05	0.000269	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—HTR1A—bipolar disorder	4.04e-05	0.000268	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—DRD1—bipolar disorder	3.99e-05	0.000264	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—HTR2C—bipolar disorder	3.99e-05	0.000264	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—TAC1—bipolar disorder	3.98e-05	0.000264	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—HTR2A—bipolar disorder	3.96e-05	0.000263	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—HTR2C—bipolar disorder	3.9e-05	0.000259	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—DRD1—bipolar disorder	3.9e-05	0.000259	CbGpPWpGaD
Alprenolol—CYP2D6—brain—bipolar disorder	3.89e-05	0.0189	CbGeAlD
Alprenolol—HTR1A—Signaling Pathways—TAC1—bipolar disorder	3.89e-05	0.000258	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—NTRK2—bipolar disorder	3.88e-05	0.000257	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—DRD3—bipolar disorder	3.86e-05	0.000256	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—GSK3A—bipolar disorder	3.84e-05	0.000255	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—HTR2C—bipolar disorder	3.81e-05	0.000253	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—DRD1—bipolar disorder	3.81e-05	0.000253	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—NTRK2—bipolar disorder	3.79e-05	0.000252	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—DRD3—bipolar disorder	3.78e-05	0.000251	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—GSK3A—bipolar disorder	3.76e-05	0.000249	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—DRD4—bipolar disorder	3.75e-05	0.000249	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—NTRK2—bipolar disorder	3.71e-05	0.000246	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—DRD3—bipolar disorder	3.69e-05	0.000245	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—GSK3A—bipolar disorder	3.68e-05	0.000244	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—DRD4—bipolar disorder	3.67e-05	0.000243	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—POMC—bipolar disorder	3.64e-05	0.000242	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—DRD4—bipolar disorder	3.58e-05	0.000238	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—POMC—bipolar disorder	3.56e-05	0.000236	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—ADCY2—bipolar disorder	3.53e-05	0.000234	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—TCF7L2—bipolar disorder	3.52e-05	0.000233	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—DRD2—bipolar disorder	3.49e-05	0.000232	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—POMC—bipolar disorder	3.48e-05	0.000231	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—ADCY2—bipolar disorder	3.45e-05	0.000229	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—TCF7L2—bipolar disorder	3.44e-05	0.000228	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—DRD2—bipolar disorder	3.42e-05	0.000227	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—ADCY2—bipolar disorder	3.37e-05	0.000224	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—TCF7L2—bipolar disorder	3.36e-05	0.000223	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—DRD2—bipolar disorder	3.34e-05	0.000222	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—GSK3B—bipolar disorder	3.32e-05	0.00022	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—POMC—bipolar disorder	3.31e-05	0.000219	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—POMC—bipolar disorder	3.29e-05	0.000218	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—INS—bipolar disorder	3.27e-05	0.000217	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—POMC—bipolar disorder	3.23e-05	0.000215	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—POMC—bipolar disorder	3.16e-05	0.00021	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—NTRK1—bipolar disorder	3.16e-05	0.00021	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—NTRK1—bipolar disorder	3.09e-05	0.000205	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—S100B—bipolar disorder	3.07e-05	0.000204	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—NTRK1—bipolar disorder	3.02e-05	0.000201	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—S100B—bipolar disorder	3.01e-05	0.000199	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—CLOCK—bipolar disorder	3e-05	0.000199	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—S100B—bipolar disorder	2.94e-05	0.000195	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—TPH2—bipolar disorder	2.92e-05	0.000194	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—TSHB—bipolar disorder	2.92e-05	0.000194	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—CACNB2—bipolar disorder	2.92e-05	0.000194	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—DPYD—bipolar disorder	2.87e-05	0.000191	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—NRG1—bipolar disorder	2.71e-05	0.00018	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—CACNA1C—bipolar disorder	2.67e-05	0.000177	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—NRG1—bipolar disorder	2.65e-05	0.000176	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—PIK3C2A—bipolar disorder	2.6e-05	0.000173	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—NRG1—bipolar disorder	2.59e-05	0.000172	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—HTR2A—bipolar disorder	2.45e-05	0.000162	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—HTR2A—bipolar disorder	2.39e-05	0.000159	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—HTR2A—bipolar disorder	2.34e-05	0.000155	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—SNAP25—bipolar disorder	2.34e-05	0.000155	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—ADCY2—bipolar disorder	2.07e-05	0.000137	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—GSK3B—bipolar disorder	1.97e-05	0.000131	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—POMC—bipolar disorder	1.95e-05	0.00013	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—INS—bipolar disorder	1.94e-05	0.000129	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—GSK3B—bipolar disorder	1.93e-05	0.000128	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—POMC—bipolar disorder	1.91e-05	0.000127	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—INS—bipolar disorder	1.9e-05	0.000126	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—GSK3B—bipolar disorder	1.88e-05	0.000125	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—POMC—bipolar disorder	1.87e-05	0.000124	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—INS—bipolar disorder	1.86e-05	0.000123	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—COMT—bipolar disorder	1.77e-05	0.000117	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—MAOA—bipolar disorder	1.76e-05	0.000117	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—MTHFR—bipolar disorder	1.43e-05	9.49e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—POMC—bipolar disorder	1.14e-05	7.59e-05	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—INS—bipolar disorder	1.14e-05	7.55e-05	CbGpPWpGaD
